Due to the BBB and the complexity of the tissue architecture, the CNS sterol homeostasis has been refractory to analysis. However, the use of conditional knock-out (or knock-in) mice in which a protein of interest is only manipulated in the brain or even in a subset of CNS cell types, is rapidly changing the situation. Two reports in the recent literature [5 ,6 ] highlight the potential of this approach and unmask novel mechanisms of cholesterol exchange between the CNS and circulating lipoproteins.
Global deficiency of squalene synthase -the first committed enzyme in the cholesterol biosynthetic pathwaypresents with embryonic lethality [7] . Conditional knockout of the enzyme in oligodendrocytes [1] or cerebellar granule cells [8] has provided insights into the role of cholesterol synthesis in myelination and neuron-glia communication, respectively. Most recently, the enzyme was inactivated from the neural stem and progenitor cells of the ventricular zone [5 ] . The authors found that the newborn neurons derived from the ventricular zone progenitors underwent apoptosis, implying that they depend on endogenous cholesterol production for survival. Perhaps more surprizingly, the ventricular zone progenitors managed to protect themselves against apoptosis by evolving a mechanism to fight the cholesterol deprivation. They upregulated the expression of vascular endothelial growth factor (VEGF), thereby promoting angiogenesis into the neurogenic niche and consequently raising their lipoprotein cholesterol supply from the blood or the neural tube.
Another example of an unexpected compensatory process, in which CNS cells evade the detrimental effects of impaired cholesterol balance by communicating with the circulating cholesterol pool, was reported by Karasinska et al. [6 ] . In the present study, mice lacking ATPbinding cassette transporter A1 (ABCA1) expression in CNS neurons and glia (ABCA1 ÀB/ÀB mice) were investigated. Earlier study using the whole-body ABCA1 knock-out model indicated that ABCA1 is critical for the secretion and lipidation of astrocyte-derived apoE [9] . In ABCA1 ÀB/ÀB mice, the turnover of brain cholesterol was increased, as judged by elevated cholesterol precursor and 24(S)-hydroxycholesterol production. The mice showed a decrease in brain cholesterol and apoE content and, remarkably, an apparently compensatory increase in the specific take-up of esterified cholesterol from plasma HDL particles into the CNS. This was accompanied by increased levels of the HDL receptor scavenger receptor class B (SR-B1) in brain capillaries.
Indeed, there is evidence that lipoprotein receptors in brain capillary endothelial cells can be used for targeted delivery of proteins across the BBB [10] . In light of the recent findings, it appears that this strategy is employed for lipid import into the CNS more commonly than hitherto appreciated. What physiological or pathological conditions this might apply to, await further investigation.
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